Melatonin is manufactured by pharmaceutical and nutraceutical companies using chemical synthesis or biotechnological processes, with production adhering to regulatory standards for dietary supplements and prescription products. Leading manufacturers include both contract development and manufacturing organizations (CDMOs) and established supplement brands.
Answer
Melatonin is a naturally occurring hormone primarily produced by the pineal gland that regulates circadian rhythms and sleep-wake cycles. Commercially, melatonin is produced synthetically to provide consistent dosage forms for supplements, over-the-counter products, and certain prescription applications. Manufactured melatonin may be delivered as tablets, capsules, gummies, or liquid formulations, often combined with excipients for stability, bioavailability, and shelf life.
Production of melatonin involves chemical synthesis under strict Good Manufacturing Practice (GMP) guidelines. This includes purification, crystallization, and quality control steps to ensure identity, potency, and microbial safety. Some manufacturers also employ biotechnological approaches, such as fermentation, to create melatonin at scale. Quality assurance (QA) and analytical testing are critical, particularly for products regulated by agencies like the U.S. Food and Drug Administration (FDA) or European Medicines Agency (EMA).
In the healthcare and nutraceutical industries, melatonin is sourced from specialized chemical manufacturers and CDMOs, supplying bulk raw materials to supplement brands or directly producing finished dosage forms. Companies focus on supply chain integrity, batch-to-batch consistency, and regulatory compliance to meet the requirements of both consumer markets and clinical applications.
Overall, manufactured melatonin provides a standardized, safe, and regulated source of this hormone, supporting sleep management, circadian rhythm modulation, and clinical research applications across global healthcare and dietary supplement markets.


